Fresenius Medical Care

Startseite
Deutschland
Bad Homburg
Fresenius Medical Care

We are the world's leading provider of products and services for individuals with renal diseases.

We are the world’s leading provider of products and services
for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. We want to go a step further towards our vision by addressing the renal care continuum and with the help of critical care solutions and complementary assets. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help our patients to enjoy the very best quality of life. Our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various
dialysis treatment options for both in-center and home dialysis that are individually tailored to our patients’ needs.

25/11/2025

What does it look like to rebuild your life — again and again? 💡
Katrin Holland has faced complex health challenges since she was 14. Years of managing type 1 diabetes, kidney failure, countless hours in dialysis centers, and two kidney transplants could have defined her story. But Katrin never stopped searching for ways to reclaim her independence.

Home hemodialysis didn’t just offer Katrin a different way to receive treatment. It allowed her to keep working, take back control of her time, and shape her everyday life around what matters most to her — not around dialysis schedules.

Her story is a powerful reminder of how personalized home care and innovative therapy options can help people living with chronic kidney disease maintain connection, purpose, and independence.

🎥 Hear in Katrin’s own words how discovering home dialysis changed her outlook and her daily life.

Learn more about home dialysis options and how they can support daily life: https://freseniusmedicalcare.com/en/patients-families/patients-families-overview/?utm_source=facebook&utm_medium=social&utm_campaign=25nov2025_homepatientstories&utm_content=global_corp

Disclaimer: Home dialysis involves risks, and users may not experience the potential benefits of such therapy. The patient statements in this post reflect their personal experiences. The described effects of the therapy may vary between individuals and specific home dialysis prescriptions. This content is not medical advice.

21/11/2025

Our Central Product Security Office, responsible for governing Product Security across the Care Enablement product portfolio, recently hosted the Cybersecurity Community Summit at our headquarters in Bad Homburg, Germany.

Over four days, experts from Cybersecurity, R&D, Regulatory, Quality, and IT aligned on future strategy of Product Security including key aspects of secure design principles, vulnerability management, and regulatory readiness in line with global expectations (FDA, EU MDR, NMPA).

The summit reinforced our ongoing dedication to embed cybersecurity into the product lifecycle and our resolve to deliver compliant, trustworthy, and secure medical and digital technologies that support the healthcare sector’s digital transformation.

20/11/2025

It’s always the right time to celebrate our company purpose and the meaningful progress we have made at Fresenius Medical Care! Yesterday’s live Global Town Hall from our North American headquarters in Waltham, Massachusetts did just that. Colleagues came together from around the world, both in-person and virtually, to reconnect, reflect, and look ahead.

At the event, we heard from Phillip Fleming, one of our home hemodialysis patients, whose inspiring story reminded us of why we do what we do. Our CEO, Helen Giza, also shared key developments and milestones of our FME Reignite strategy, and members of the Management Board joined the Q&A to answer questions from the audience.

Our incoming CEO of Care Enablement, Joe Turk, starting January 1, 2026, joined the stage alongside Tommy O’Connor, the new CEO of Interwell Health, who leads our Value-Based Care segment.

As Helen said, we’re closing in on a strong year – and stepping into our FME Reignite era with purpose and focus. A heartfelt thank you to everyone who joined us and to our team who brought this energizing event to life!

We are !

20/11/2025

Living well isn’t about big changes; it’s about the small, consistent choices we make every day.

For those living with or at risk of diabetes, these small steps are the foundation of a healthier life. From walking after meals to getting quality sleep, simple choices can make a meaningful difference in managing blood sugar and improving overall health.

👉 Swipe to see four practical tips that can help you on your health journey.

Find inspiration and helpful resources here: https://freseniusmedicalcare.com/en/media/insights/together/world-diabetes-day-2025/?utm_source=facebook&utm_medium=social&utm_campaign=wdd2025_organicsome&utm_content=20_nov_25

18/11/2025

How far would you go to protect new life while fighting for your own? 🌟👶
When Yvonne Khoo learned she had kidney failure during her pregnancy, everything changed in an instant. She was suddenly faced with heartbreaking choices, conflicting medical advice, and the fear of what the future might hold for her family.

In this emotional personal story, Yvonne reflects on the courage it took to continue her pregnancy, the challenges that followed, and how starting peritoneal dialysis at home helped her regain strength, energy, and a sense of control over her daily life.

Her journey shines a light on the resilience of people living with kidney disease and the impact that empowering, person-centered care can have when life takes an unexpected turn.

🎥 Watch Yvonne’s story to hear the moment that changed everything and what helped her move forward with hope.

Learn more about home dialysis options and how they can support daily life: https://freseniusmedicalcare.com/en/patients-families/patients-families-overview/?utm_source=facebook&utm_medium=social&utm_campaign=18nov2025_homepatientstories&utm_content=global_corp

Disclaimer: Home dialysis involves risks, and users may not experience the potential benefits of such therapy. The patient statements in this post reflect their personal experiences. The described effects of the therapy may vary between individuals and specific home dialysis prescriptions. This content is not medical advice.

17/11/2025

For this year's World Diabetes Day and awareness month, Fresenius Medical Care joined the global community under this year’s theme, “Diabetes and Well-being,” to highlight the importance of supporting the physical, mental, and emotional health of people living with diabetes and those at risk.

In a special interview, Dr. Benjamin Hippen, our Chief Medical Officer for Care Delivery at Fresenius Medical Care, discusses the global impact of diabetes, its connection to kidney health, and the importance of early detection.

View the video below, and check our short news via the link to discover our educational resources, personal stories, and expert insights to empower patients, caregivers, employees, and others: https://freseniusmedicalcare.com/en/media/newsroom/world-diabetes-day-2025/?utm_source=facebook&utm_medium=social&utm_campaign=wdd2025_shortnews&utm_content=global_corp

14/11/2025

On this , we pause to recognize the very human side of diabetes.

For many of our colleagues, living well with diabetes is a constant juggling act that goes far beyond managing glucose levels and medication. It’s about resilience, navigating invisible challenges, and the profound impact of a workplace that leads with empathy and trust. 💙

In this video, you’ll hear their honest reflections on living with or caring for someone with diabetes, and the difference that small, everyday acts of support can make. 🌟

“The people I work with are so professional and embrace the whole concept of caring for people. It is the caring culture here that makes me feel safe,” says Roxana, Fresenius Medical Care business systems analyst, living well with Type 1 diabetes for 55 years.

👉 Watch their stories and explore more insights here: https://freseniusmedicalcare.com/en/media/insights/together/world-diabetes-day-2025/?utm_source=facebook&utm_medium=social&utm_campaign=wdd2025_organicsome&utm_content=14_nov_25

13/11/2025

Thank you, ASN Kidney Week 2025! 💙 What an inspiring week of scientific exchange, collaboration, and forward-thinking discussions on how we can continue improving kidney care worldwide.

We are truly grateful to everyone who joined our scientific sessions, visited our booth, engaged with our experts, and contributed to meaningful conversations throughout the event. Your insights, questions, and perspectives are what make ASN such a powerful platform for advancing nephrology together.

If you attended one of our sessions or would like to revisit key learnings, stay connected – we will be sharing highlights, scientific takeaways, and next steps on our journey to advance kidney care.

👉 Swipe through the photos to relive some of our key moments from this year’s congress.

We look forward to seeing you again at ASN Kidney Week 2026! 🤝

For more information, please visit: https://freseniusmedicalcare.com/en-us/asn-2025/?utm_source=social&utm_medium=facebook&utm_campaign=kidneyweek2025&utm_content=asn_2025_13nov2025&utm_term=organic4

07/11/2025

At ASN Kidney Week 2025, Fresenius Medical Care presented new real-world evidence linking hemodiafiltration (HDF) to improved outcomes for dialysis patients. The oral presentation, “Hemodiafiltration is associated with reduced risk of cardiovascular and fluid-related hospitalization outcomes” was delivered by researchers from our Global Medical Office and The Renal Research Institute (RRI), a subsidiary of Fresenius Medical Care.

Drawing on data from more than 70,000 dialysis patients treated in Fresenius Medical Care NephroCare Clinics in Europe between 2019 and 2022, the study found that HDF was associated with significantly lower rates of cardiovascular- and fluid-related hospitalizations compared to high-flux hemodialysis. The results showed reductions in both hospital admissions and hospital days.
We thank all who attended the session and joined the discussion on how data-driven insights and innovation are advancing kidney care worldwide.

For more information, check out our website: https://freseniusmedicalcare.com/en-us/asn-2025/?utm_source=social&utm_medium=facebook&utm_campaign=kidneyweek2025&utm_content=asn_2025_07nov2025&utm_term=organic3

We thank the authors of the abstract: Yan Zhang, Anke Winter, Linda Hanna Ficociello, Paola Carioni, Otto Árkossy, Michael Anger, Robert Kossmann, Len Usvyat, and Stefano Stuard 💙

06/11/2025

Fresenius Medical Care was proud to host the breakfast symposium “HighVolumeHDF: The Next Standard of Care for U.S. Patients – Evidence and Practical Use” as part of the ASN Kidney Week 2025 Exhibitor Spotlight series. The session brought together experts to discuss clinical evidence and real-world insights from outside the U.S., showing how hemodiafiltration (HDF) may help improve patient outcomes.

The conversation highlighted growing interest in adopting HighVolumeHDF within the U.S. Panelists also discussed the operational and clinical considerations of implementing HDF in routine practice, emphasizing the importance of collaboration and education.

We were delighted by the energy and engagement from attendees, reflecting a shared commitment to redefining standards of care in nephrology. Visit us at booth # 1815 to learn more about our research, clinical collaborations, and ongoing innovations in kidney care.

For more information, check out our website: https://freseniusmedicalcare.com/en-us/asn-2025/?utm_source=social&utm_medium=facebook&utm_campaign=kidneyweek2025&utm_content=asn_2025_06nov2025&utm_term=organic2

05/11/2025

Let's talk about one of the world’s fastest-growing health challenges affecting many individuals and families: Diabetes.

🌍 1 in 9 adults live with diabetes.
😮 4 in 10 don’t know they have it.

Unmanaged diabetes is the leading cause of kidney failure, a serious condition that can progress silently for years before showing symptoms. But the risks don't stop there. It also increases the chances of other serious health challenges, like heart disease, vision loss, and dementia.

Early detection matters. By acting today, you can make all the difference in protecting your health.

👉 Explore our campaign page for helpful information, practical tips, and a link to the free risk assessment by the International Diabetes Federation: https://freseniusmedicalcare.com/en/media/insights/together/world-diabetes-day-2025/?utm_source=facebook&utm_medium=social&utm_campaign=wdd2025_organicsome

Start your journey to living well today.

04/11/2025

News 📢: This morning, Fresenius Medical Care published its Q3 2025 financial results, further accelerating organic revenue growth and delivering a 28% increase in operating income in the third quarter. Read the full release below.

The results of Q3 2025 underline our ongoing operational and financial progress, as all three operating segments contributed to strong organic revenue growth of 10% at constant currency, and the accelerated operating income drove a step-change in margin expansion to 11.7%.

The FME25+ program continued its positive momentum, delivering EUR 47 million additional sustainable savings. In the first nine months, FME25+ has already delivered EUR 174 million in additional annual savings.

Quote, CEO Helen Giza: “In Q3 of 2025, we continued the momentum and further accelerated revenue growth. Conversion into operating income growth increased as planned for the third consecutive quarter, underlining our continued operational and financial progress. Our Group operating income margin of 11.7% extended well into the implied full year 2025 range of 11% to 12%. This demonstrates important progress on our trajectory to deliver our full year 2025 financial outlook. All three operating segments contributed to the Group organic growth of 10%. U.S. same market treatment growth was slightly positive in Q3. Operating income in Care Enablement grew strongly by 38%, leading to a margin of 7.6%. In parallel, Care Delivery significantly improved profitability, reaching a strong margin of 14.5%, at the top end of its 2025 target margin band.”

Helen Giza added: “We advanced our FME Reignite strategy for value creation with the launch of the first tranche of our initial share buyback program, the ownership increase in our Value-Based Care entity Interwell Health and the continued rollout of the 5008X in the U.S. For 2025, we are well on track to achieve our commitments, while we are excited about what lies ahead with FME Reignite.”

Read more in today’s press release: https://freseniusmedicalcare.com/en/media/newsroom/q3-2025/?utm_source=social&utm_medium=facebook&utm_campaign=financialearnings&utm_content=q3_financial_earnings_05nov2024&utm_term=global

Adresse

Else-Kroener-Str. 1
Bad Homburg
61352

Telefon

+4961726090

Webseite

http://www.freseniusmedicalcare.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Fresenius Medical Care erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.